About us

The registered association AGMT is a non-profit association of scientifically active clinicians and researchers in the fields of haematology and oncology, among others. We have set ourselves the goal,  

to carry out clinical studies to improve the results of treating patients suffering from malignant tumours

to facilitate investigations for better understanding of the results of treating malignant tumors

to perform scientific and associated translational research, which can enable the control of modern therapeutic procedures or better understanding of therapeutic success

to organise further training for advanced and continued scientific and clinical courses in Austria

In order to be able to implement the objectives of AGMT professionally, the AGMT gemeinnützige GmbH (non-profit organisation) was established in 2007, which AGMT has taken over as a 100% subsidiary of the educational arm of the association.

We offer a professional platform for the implementation of clinical trials, covering all aspects of a clinical trial, from initiation to execution and follow-up, in accordance with the relevant provisions of the AMG and ICH GCP. In addition, AGMT has been ISO 9001 certified in the field of quality management since 2014. The implementation of quality assurance measures results in a systematic increase in quality and minimizes risks for all our partners.

Univ. Prof. Dr. Richard Greil - CEO AGMT

Our policy statement

We act in accordance with our 5 principles:

  1. 1
    Partner orientation

    The stable quality of our research work is one of the essentials of our successful social activity. For us, quality means meeting the requirements of our project and contractual partners in the best possible way. In this respect, quality is an important criterion for the awarding of projects and forms a reliable link to our research partners.

  2. 2
    Quality of our research work

    A trouble-free organisation and the most advanced quality management methods provide the necessary framework for this. Our understanding and awareness of quality as well as the correct attitude of all employees towards quality are prerequisites for the satisfaction of our research partners and thus for the lasting success of our research group.

  3. 3

    For us, acting with quality in mind also means handling valuable resources efficiently and carefully. All employees have the duty and the right to work towards the elimination of circumstances that prevent the performance of work of impeccable quality.

    For us, the continuous improvement of quality is therefore also a medium- and long-term prerequisite for effective management in the sense of public benefit and an important contribution to the protection of the environment.

  4. 4

    AGMT collaborates with highly qualified specialists from leading institutions in Austria and neighbouring countries to conduct clinical studies. The quality and success of AGMT studies are ensured by the integration of relevant sites with an oncological focus. In order to continue to meet our goals, we are continuously expanding our cooperation with interested specialists, institutions and study groups.

  5. 5
    Quality objectives

    The Austrian Group Medical Tumor Therapy (AGMT) is a non-profit association of active clinicians and researchers in the fields of haematology, oncology and other medical disciplines. The quality goals serve the implementation of the quality policy.

    Our quality objectives are:

    • To carry out clinical studies to improve the treatment results of patients with malignant tumors.
    • Enable clinical trials to improve the understanding of treatment outcomes of malignant tumor diseases
    • To carry out basic scientific and translational accompanying research, which can allow the control of modern therapy methods or a better understanding of therapy success
    • To organise training courses to improve scientific and clinical education and training in Austria.
    • Implementation of clinical projects according to GCP-ICH and all relevant legal regulations and guidelines.
    • Presentation of clinical projects at national and international congresses
    • Publication of research results in renowned international journals
    • Compliance with the legal material relevant to data protection